INTRODUCTION

44
The prokaryotic clustered regularly interspaced short palindromic repeats (CRISPR) system were trimmed by Trim Galore
142
(http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/; v0.3.7) and then aligned to 143 the hg38 reference genome using STAR v2.6.0c. 21 Differentially expressed protein-coding 
170
To investigate the VP16-based CRISPR activation system, we first designed a vector for the 171 human expression of both a scrambled gRNA and the dCas9 fused to ten repeats of VP16 172 (VP160). In order to discriminate between transfected and non-transfected cells, green 173 fluorescent protein (GFP) was fused to the VP160 open reading frame using a linker encoding 174 the cleavable peptide 2A. 28 We used the system to target the endogenous activation of CD34, 175 a gene which is not expressed in HEK 293 cells (https://www.proteinatlas.org). 29 CD34 176 encodes a transmembrane protein, allowing us to discriminate easily by antibody recognition 177 the cells expressing the protein in living cells. In a prior study, VP16 repeats directly fused to 178 dCas9 required a pool of gRNAs for robust activation, 8 increasing the number of possible 179 mismatches that could lead to off-target activation genome-wide. To test the off-target effects 180 from multiple gRNA sequences, dCas9-VP160-2A-GFP was transfected in combination with 181 six pooled gRNAs targeting the CD34 promoter ( Fig. 1A) . Performing fluorescence-activated 182 cell sorting (FACS), we demonstrated successfully induced endogenous expression of CD34 183 in HEK 293T cells ( Fig. 1B) , with GFP+/CD34+ cells, showing an 80-fold increase in CD34 184 mRNA levels (Fig. 1C) . Interestingly, successfully transfected cells not expressing CD34 on 185 the cell surface (GFP+/CD34-) also had an increase in CD34 mRNA levels (Fig. 1C) ,
186
suggesting a cell subpopulation with either delayed protein translation or a lack of membrane 187 translocation. While the pooled gRNAs were indeed more effective in inducing CD34 trans-188 membrane expression compared to individual gRNAs, individual gRNA sequences seeding 189 within a short distance (up to 100 nucleotides) from the transcriptional start site (TSS) were 190 also successful, with expression levels increasing with decreasing distances from the TSS 191 ( Supplementary Fig. 1 ).
192
To evaluate whether the system induced undesirable effects genome-wide, we conducted
193
RNA-seq analyses on the GFP+ cells transfected with the full activation system including the 194 six gRNAs (CRISPR CD34), in comparison to non-transfected cells (Control). In addition to 195 the strong upregulation of CD34, a total of 161 differentially expressed genes were identified 196 ( Fig. 2A) . We then generated a CRISPR control by sorting GFP+ cells expressing dCas9-
197
VP160 and a scrambled gRNA (CRISPR). In this control, we detected 125 differentially 198 expressed genes ( Fig. 2B) , with 97 of them overlapping the genes identified in the CRISPR
199
CD34 sample ( Fig. 2C, Supplementary file 2) . Predicted gRNA off-target loci were not within 200 1kb of the dysregulated genes' TSSs, suggesting that their differential expression was not a 201 result of targeted dCas9-VP160 activation.
202
Nevertheless, the consistently dysregulated genes observed in the CRISPR control cells 203 raised the question of whether side effects may occur due to the expression of dCas9, VP16 204 repeats, or gRNAs. We evaluated these 97 genes through functional enrichment analysis and 205 protein associations. The gene ontology analysis was significantly enriched for biological 206 pathways related to apoptosis, response to cytokines, mechanical stimulus, inflammation, and 207 response to endoplasmic reticulum stress and unfolded proteins, represented by a total of 30 208 genes. Further analysis of protein-protein associations related to those genes featured the 209 pathways of cell defense and regulation of cell death ( Fig. 3) , from which we selected three 210 node genes (DDIT3, RELB, and JUNB) for further investigation.
211
DDIT3 encodes the DNA Damage Inducible Transcript 3 transcription factor activated during 212 endoplasmic reticulum stress. 30 RELB is a subunit of the pleiotropic transcription factor NFκB 213 that has a central role in cell differentiation, growth, apoptosis, inflammation, and immunity. 31-214 33 JUNB, a component of the AP1 transcription factor, has a role in stress response and is 215 associated with the NFκB pathway. [34] [35] [36] [37] 216
Assessing the impact of the various CRISPR activation system components, we quantified the 217 changes in expression of the selected genes in GFP+ cells transfected with distinct CRISPR 218 components ( Fig. 4A) 227 expression ( Fig. 4B) .
228
We then investigated whether cells transfected with the CRISPR activation system were able 229 to return to their basal expression levels over multiple cell divisions. To do this, we kept the 230 activated GFP+ cells in culture until cells were negative for GFP fluorescence under the 231 microscope (after 10 cell divisions). At this point, the cells were analyzed by FACS and sorted 232 for GFP-populations to ensure that the CRISPR components had been eliminated from the 233 cells. We demonstrated that the upregulated stress-response genes returned to their basal 234 levels ( Fig. 5) , indicating the absence of a memory effect for both CD34 and the cellular stress 
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The outcome of undesirable transcriptional regulation is of concern when using dCas9 fused (FOSL1)  FOSL1  ENSG00000006327  TNF receptor superfamily member 12A(TNFRSF12A)  TNFRSF12A  ENSG00000148677 ankyrin repeat domain 1(ANKRD1) NKRD1 ENSG00000099860 growth arrest and DNA damage inducible beta(GADD45B) GADD45B ENSG00000119922
interferon induced protein with tetratricopeptide repeats 2(IFIT2) IFIT2 ENSG00000176046 nuclear protein 1, transcriptional regulator(NUPR1) NUPR1 ENSG00000161011 sequestosome 1(SQSTM1) SQSTM1 ENSG00000145147 slit guidance ligand 2(SLIT2) SLIT2 ENSG00000265972 thioredoxin interacting protein(TXNIP) TXNIP ENSG00000171223
JunB proto-oncogene, AP-1 transcription factor subunit(JUNB) JUNB ENSG00000104856
RELB proto-oncogene, NF-kB subunit(RELB) RELB ENSG00000160712
interleukin 6 receptor(IL6R) IL6R ENSG00000077150
nuclear factor kappa B subunit 2(NFKB2) NFKB2 ENSG00000128965
ChaC glutathione specific gamma-glutamylcyclotransferase 1(CHAC1) CHAC1 ENSG00000175197
DNA damage inducible transcript 3(DDIT3) DDIT3 ENSG00000087074
protein phosphatase 1 regulatory subunit 15A(PPP1R15A) PPP1R15A ENSG00000101255
tribbles pseudokinase 3(TRIB3) TRIB3 ENSG00000169429
C-X-C motif chemokine ligand 8(CXCL8) CXCL8 ENSG00000049249
TNF receptor superfamily member 9(TNFRSF9) TNFRSF9 ENSG00000163661 pentraxin 3(PTX3) PTX3 ENSG00000105499 phospholipase A2 group IVC(PLA2G4C) PLA2G4C ENSG00000171951
secretogranin II(SCG2) SCG2 ENSG00000159307 signal peptide, CUB domain and EGF like domain containing 1(SCUBE1) SCUBE1 ENSG00000006128 tachykinin precursor 1(TAC1) TAC1 ENSG00000070669 asparagine synthetase (glutamine-hydrolyzing)(ASNS) ASNS ENSG00000120738 early growth response 1(EGR1) EGR1 ENSG00000135423 glutaminase 2(GLS2) GLS2 ENSG00000180447 growth arrest specific 1(GAS1) GAS1 ENSG00000130513 growth differentiation factor 15(GDF15) GDF15 ENSG00000115129
tumor protein p53 inducible protein 3(TP53I3) TP53I3
